Our study indicates that the SATB2/CBP transcriptional complex plays critical roles in maintaining GSC property to sustain GBM tumor growth, suggesting that targeting the STAB2/CBP signaling axis may significantly improve survival of GBM patients. The gene discussed is SATB2; the disease is glioblastoma.